Market Tracker

12/11 5:15pm ET

SPDR® S&P Pharmaceuticals ETF (XPH)

Delayed Data
As of Dec 11
 +0.34 / +0.79%
Today’s Change
Today|||52-Week Range

Investment Objective

The investment seeks to provide investment results that- before fees and expenses- correspond generally to the total return performance of an index derived from the pharmaceuticals segment of a U.S. total market composite index. In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index")- the fund employs a sampling strategy. It generally invests substantially all- but at least 80%- of its total assets in the securities comprising the index. The index represents the pharmaceuticals segment of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.

No recent news for SPDR® S&P Pharmaceuticals ETF.


1 month+5.89% 3 years-5.36%
3 months-0.40% 5 years+12.49%
1 year+13.22% Since inception+11.52%
Data through 12/09/2017

Quote Details

Previous close$43.03
Open day’s range43.06 – 43.65
Net asset value (NAV)43.05 (12/08/2017)
Daily volume82,460
Average volume (3 months)101,525
Data as of 8:00pm ET, 12/11/2017

Peer Comparisonvs. Health ETFs

Performance 5-yr return+12.49%+16.79%
Expense Gross exp ratio0.35%1.33%
Risk 5 year sharpe ratio0.661.12
Net assets$402.4M$3.1B
Average market cap$9.6B$27.3B
Average P/E27.722.4
Dividend / Share--0.30%


XLV Health Care Select Sector SPDR® Fund
RYH Guggenheim S&P 500® Equal Weight Health...
VHT Vanguard Health Care Index Fund ETF Shar...


Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
NKTR Nektar Therapeutics5.21%
MYL Mylan NV5.17%
ZTS Zoetis Inc5.07%
JNJ Johnson & Johnson4.83%
PFE Pfizer4.83%
PRGO Perrigo Company PLC4.78%
HZNP Horizon Pharma PLC4.67%
LLY Eli Lilly and Co4.64%
BMY Bristol-Myers Squibb4.58%
AKRX Akorn Inc4.47%